Biogen
BIIB
#991
Rank
โ‚น1.654 T
Marketcap
โ‚น11,300
Share price
-3.52%
Change (1 day)
-36.94%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

EPS for Biogen (BIIB)

EPS in 2023 (TTM): โ‚น1,513

According to Biogen's latest financial reports the company's current EPS (TTM) is โ‚น1,580. In 2022 the company made an earnings per share (EPS) of โ‚น1,796 an increase over its 2021 EPS that were of โ‚น892.65.

EPS history for Biogen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น1,513-15.77%
2022โ‚น1,796101.25%
2021โ‚น892.65-57.43%
2020โ‚น2,097-22.27%
2019โ‚น2,69845.66%
2018โ‚น1,85281.39%
2017โ‚น1,021-29.62%
2016โ‚น1,45110.28%
2015โ‚น1,31523.65%
2014โ‚น1,06457.94%
2013โ‚น673.5535.92%
2012โ‚น495.5413.53%
2011โ‚น436.4827.82%
2010โ‚น341.4818.4%
2009โ‚น288.4226.22%
2008โ‚น228.5132.18%
2007โ‚น172.88215.63%
2006โ‚น54.7733.33%
2005โ‚น41.08562.52%
2004โ‚น6.20-101.48%
2003-โ‚น420.22-606.19%
2002โ‚น83.02-47.28%
2001โ‚น157.48147.52%
2000โ‚น63.62-311.38%
1999-โ‚น30.1048.59%
1998-โ‚น20.2694.52%
1997-โ‚น10.4119.67%
1996-โ‚น8.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,211-23.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น375.72-76.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น315.01-80.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น159.19-89.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,205-23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น836.81-152.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น272.18-82.77%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น489.55-130.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2,277-244.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น124.46-92.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands